Virtu Financial’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Virtu Financial’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,128	Closed	-$49K	–	1863
2025 Q3	$49K	Buy	+13,128	New	+$44.5K	﹤0.01%	1136
2024 Q3	–	Sell	-587	Closed	-$7K	–	1557
2024 Q2	$7K	Buy	+587	New	+$9.27K	﹤0.01%	1161
2021 Q4	–	Sell	-983	Closed	-$88K	–	1884
2021 Q3	$88K	Buy	983 +468	+91%	+$50K	0.01%	1176
2021 Q2	$65K	Buy	+515	New	+$70.2K	0.01%	1289

Other funds holding DMRA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Virtu Financial's DMRA Position: Q4 2025 in Review

Virtu Financial sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q4 2025, closing a stake of 13,128 shares — an estimated $49K sold.

Virtu Financial first reported a position in DMRA in Q2 2021 and held it in 4 quarters. The position peaked at $88K in Q3 2021. 18 funds tracked by Wall St. Rank hold DMRA as of Q4 2025.

Virtu Financial reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 13,128 Damora Therapeutics, Inc. Ordinary Shares shares in Q4 2025, an estimated $49K.
Virtu Financial first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q2 2021 and held it in 4 quarters.
Virtu Financial's Damora Therapeutics, Inc. Ordinary Shares position peaked at $88K in Q3 2021.
18 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.